Current and Emerging Treatment Options for Multidrug Resistant Escherichia coli Urosepsis: A Review

por Walker, Mikaela M., Roberts, Jason A., Rogers, Benjamin A., Harris, Patrick N. A., Sime, Fekade B.
Publicado 2022

1573. Population Pharmacokinetic Analyses for Cefepime in Adult and Pediatric Patients

por Liu, Jiajun, Neely, Michael, Lipman, Jeffrey, Sime, Fekade B, Roberts, Jason, Kiel, Patrick J, Scheetz, Marc H
Publicado 2019

Pharmacokinetics of Intravenous Posaconazole in Critically Ill Patients

por Sime, Fekade B., Stuart, Janine, Butler, Jenie, Starr, Therese, Wallis, Steven C., Pandey, Saurabh, Lipman, Jeffrey, Roberts, Jason A.
Publicado 2018

P15 Evaluation of the stability of temocillin in elastomeric infusion devices used for outpatient parenteral antimicrobial therapy in accordance with the requirements of the UK NHS...

por Sime, Fekade B., Wallis, Steven C., Jamieson, Conor, Hills, Tim, Gilchrist, Mark, Santillo, Mark, Seaton, R. Andrew, Drummond, Felicity, Roberts, Jason A.
Publicado 2022

Population Pharmacokinetics of Unbound Ceftolozane and Tazobactam in Critically Ill Patients without Renal Dysfunction

por Sime, Fekade B., Lassig-Smith, Melissa, Starr, Therese, Stuart, Janine, Pandey, Saurabh, Parker, Suzanne L., Wallis, Steven C., Lipman, Jeffrey, Roberts, Jason A.
Publicado 2019

A Population Pharmacokinetic Model-Guided Evaluation of Ceftolozane-Tazobactam Dosing in Critically Ill Patients Undergoing Continuous Venovenous Hemodiafiltration

por Sime, Fekade B., Lassig-Smith, Melissa, Starr, Therese, Stuart, Janine, Pandey, Saurabh, Parker, Suzanne L., Wallis, Steven C., Lipman, Jeffrey, Roberts, Jason A.
Publicado 2019

Cerebrospinal Fluid Penetration of Ceftolozane-Tazobactam in Critically Ill Patients with an Indwelling External Ventricular Drain

por Sime, Fekade B., Lassig-Smith, Melissa, Starr, Therese, Stuart, Janine, Pandey, Saurabh, Parker, Suzanne L., Wallis, Steven C., Lipman, Jeffrey, Roberts, Jason A.
Publicado 2020

Impact of the Epithelial Lining Fluid Milieu on Amikacin Pharmacodynamics Against Pseudomonas aeruginosa

por Heffernan, Aaron J., Sime, Fekade B., Lim, Sazlyna Mohd Sazlly, Naicker, Saiyuri, Andrews, Katherine T., Ellwood, David, Lipman, Jeffrey, Grimwood, Keith, Roberts, Jason A.
Publicado 2021

Population pharmacokinetics of total and unbound concentrations of intravenous posaconazole in adult critically ill patients

por Sime, Fekade B., Byrne, Catherine J., Parker, Suzanne, Stuart, Janine, Butler, Jenie, Starr, Therese, Pandey, Saurabh, Wallis, Steven C., Lipman, Jeffrey, Roberts, Jason A.
Publicado 2019

Evaluating Mono- and Combination Therapy of Meropenem and Amikacin against Pseudomonas aeruginosa Bacteremia in the Hollow-Fiber Infection Model

por Avent, Minyon L., McCarthy, Kate L., Sime, Fekade B., Naicker, Saiyuri, Heffernan, Aaron J., Wallis, Steven C., Paterson, David L., Roberts, Jason A.
Publicado 2022

Ex Vivo Characterization of Effects of Renal Replacement Therapy Modalities and Settings on Pharmacokinetics of Meropenem and Vaborbactam

por Sime, Fekade B., Pandey, Saurabh, Karamujic, Nermin, Parker, Suzanne, Alexander, Elizabeth, Loutit, Jeffery, Durso, Stephanie, Griffith, David, Lipman, Jeffrey, Wallis, Steven C., Roberts, Jason A.
Publicado 2018

Pharmacodynamic evaluation of piperacillin/tazobactam versus meropenem against extended-spectrum β-lactamase-producing and non-producing Escherichia coli clinical isolates in a hol...

por Islam, Kamrul, Sime, Fekade B, Wallis, Steven C, Bauer, Michelle J, Forde, Brian M, Harris, Patrick, Shirin, Tahmina, Habib, Zakir H, Flora, Meerjady S, Roberts, Jason A
Publicado 2022